Cytotheryx, Inc.
- Biotech or pharma, therapeutic R&D
- Medical device or technology
- Other R&D services
Cytotheryx is developing cell-based therapies to address acute, chronic and rare forms of liver disease. Enabled by our proprietary bio-incubator that propagates a scalable, clinically relevant source of primary human hepatocytes, the functional cell of the liver, Cytotheryx is working to address the enormous unmet need for patients with liver disease. Our platform technology is licensed from Mayo Clinic.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}